Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin (Q37081037)
scientific article published on 13 January 2009
Language:
(P31) (Q13442814)
(P304) 334-343
(P407) (Q1860)
(P433) 2
(P478) 100
(P577) Tuesday, January 13, 2009
(P1433) (Q326309)
(P1476) "Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin" (language: en)
(P2093) X Wu
A Wanders
P Wardega
B Tinge
L Gedda
S Bergstrom
L Sooman
J Gullbo
M Bergqvist
P Hesselius
J Lennartsson
S Ekman
(P2860) (Q34803792)
(Q40058972)
(Q36610597)
(Q36095735)
(Q36899860)
(Q40111740)
(Q40117631)
(Q40149432)
(Q36760976)
(Q40158485)
(Q29615474)
(Q40183847)
(Q40230466)
(Q40338078)
(Q29614217)
(Q35787276)
(Q35601108)
(Q35587293)
(Q40632085)
(Q35099516)
(Q27640863)
(Q40766713)
(Q34052682)
(Q34487157)
(Q221226)
(Q33889333)
(Q37044062)
(Q42471183)
(Q42169842)
(Q42520983)
(Q45141950)
(Q41886360)
(Q53590147)
(Q46706373)
(Q47970565)
(Q44705946)
(Q44216771)
(Q56209683)
(Q79983765)
(Q79862448)
(Q79522451)
(Q80114123)
(Q80727102)
(Q81343360)
(Q59616907)
(Q74185738)
(Q77507536)
other details
description scientific article published on 13 January 2009

External Links